Analyst Ratings February 11, 2026

Truist Cuts Rapid7 Price Target to $8, Maintains Hold After Mixed Q4 Results

Analysts trim forecasts as conservative 2026 outlook and customer conversion issues pressure the cybersecurity firm's near-term growth trajectory

By Jordan Park RPD SAIA
Truist Cuts Rapid7 Price Target to $8, Maintains Hold After Mixed Q4 Results
RPD SAIA

Truist Securities reduced its price target on Rapid7 to $8.00 from $14.00 while keeping a Hold rating after the company's fourth-quarter 2025 report. The revision comes amid mixed quarter results, a below-consensus revenue outlook, and management moves intended to jump-start growth; several other brokerages also moved to trim targets or ratings following Rapid7's conservative 2026 guidance.

Key Points

  • Truist cut Rapid7's price target to $8.00 from $14.00 and kept a Hold rating; the target is slightly above the recent share price of $7.82.
  • Rapid7 reported mixed fourth-quarter 2025 results that were roughly in line with estimates but issued revenue guidance below consensus and withheld ARR guidance for fiscal 2026, per Truist.
  • Several other brokerages also reduced price targets or ratings after Rapid7's conservative 2026 outlook, reflecting broad analyst caution.

Truist Securities lowered its price target for Rapid7 (NASDAQ:RPD) to $8.00 from $14.00 on Wednesday and kept a Hold rating on the cybersecurity provider's shares. The new target sits just above Rapid7's most recent market price of $7.82, with the stock trading near a 52-week low of $10.20.

The price-target cut followed Rapid7's fourth-quarter 2025 earnings release, which Truist characterized as mixed and roughly in line with its estimates. After the announcement, Rapid7's shares fell about 21% in after-hours trading. Despite the selloff, InvestingPro data cited by Truist indicates the company posted a diluted EPS of $0.36 over the last twelve months, and technical indicators such as the RSI suggest the shares have entered oversold territory.

Truist's analysis highlights several elements of concern in the report. Revenue guidance for the upcoming period came in below consensus expectations, and management did not provide annual recurring revenue guidance for fiscal 2026, according to the research firm. Those omissions contributed to a cautious tone from analysts.

The research note also detailed operational headwinds. Rapid7's management announced organizational changes and strategic pivots aimed at re-accelerating growth, but Truist pointed to deceleration within the company's detection and response business. Growth in that segment reportedly slowed from "mid-teens" in the third quarter to "high single-digits." Truist additionally flagged ongoing difficulties converting core vulnerability management customers onto Rapid7's Exposure Management platform, and said it would remain cautious until there are clear signs of a growth inflection.

Other analyst activity followed Rapid7's conservative outlook for 2026. Scotiabank lowered its price target to $9 from $18 and maintained a Sector Perform rating. JP Morgan dropped its target to $11 from $20. Canaccord Genuity moved the stock from Buy to Hold and reduced its price target to $10 from $27. These actions underscore a broadly cautious view among analysts after the guidance shifted investor expectations.

Separately noted in recent market reports, Saia reported fourth-quarter 2025 earnings per share of $1.77, below Evercore ISI's forecast of $1.95 and the average Street estimate of $1.90. Saia's revenue exceeded expectations, driven by improved volumes and yield, though EBIT and the operating ratio missed projections in part due to higher insurance costs. Evercore ISI reacted by raising its price target for Saia to $435 from $367 while keeping an "In Line" rating.

For Rapid7 specifically, the company posted fourth-quarter 2025 EPS of $0.44, ahead of the expected $0.41, and revenue of $217.39 million versus a forecast of $215.03 million. Even with those upside results for the quarter, the conservative 2026 outlook prompted the wave of analyst adjustments and contributed to near-term share price pressure.


Contextual takeaway: Analysts trimmed valuations and expressed guarded sentiment after Rapid7’s Q4 print, citing below-consensus guidance, slowing growth in key business lines, and conversion challenges as reasons to await clearer signs of a sustained growth inflection before upgrading conviction.

Risks

  • Revenue guidance below consensus and the lack of ARR guidance increase near-term visibility risk for shareholders - this primarily affects the cybersecurity and enterprise software sectors.
  • Decelerating growth in the detection and response business and slow conversion of vulnerability management customers to Exposure Management create execution risk for Rapid7's product strategy - impacting enterprise security spend and mid-cap cybersecurity equities.
  • Analyst downgrades and price-target cuts can put additional downward pressure on the stock, which may amplify volatility in the security's market performance - relevant to portfolio managers and equity traders focused on software and security names.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026